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Introduction: The cardiovascular consequences related to amyotrophic lateral sclerosis are relatively
underappreciated. The disease invokes a systematic degeneration of autonomic neurons leading to autonomic
dysfunction. We therefore hypothesized that patients with amyotrophic lateral sclerosis may have a predilection to
the development of cardiac conduction disorders.
Case presentation: A 65-year-old Caucasian man with advanced amyotrophic lateral sclerosis presented with
progressive dyspnea and palpitations. A previous evaluation attributed his dyspnea to neuromuscular weakness and
he underwent a pulmonary evaluation. Pulmonary function tests did not indicate a worsening from baseline. An
electrocardiogram was obtained which demonstrated new third degree atrioventricular block. A previously obtained
electrocardiogram indicated normal sinus rhythm. On echocardiogram, a structurally normal heart was observed
without significant valvular disease. He was offered a permanent dual chamber pacemaker for definitive treatment,
however, he declined.
Conclusions: We believe that his symptoms were probably attributable to atrioventricular block. Patients with
advanced amyotrophic lateral sclerosis experience loss of heart rate variability and enhanced vasomotor responses.
As patients progress later in the disease, sympathetic denervation and vagal predominance contribute to the
development of atrioventricular block. We conducted a query using the Explorys database of patients with
amyotrophic lateral sclerosis and heart block. The prevalence of heart block was estimated to be 25% higher in
patients with the disease as compared to the general population. This is the first reported case that attempts to
describe the relationship of atrioventricular block with amyotrophic lateral sclerosis.
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The cardiovascular consequences related to amyotrophic
lateral sclerosis (ALS) are relatively underappreciated.
Well-characterized consequences of the illness are
derangements related to the autonomic nervous system
which include critical mechanisms involved in regulating
blood pressure, heart rate, and other homeostatic
functions such as digestion and temperature regulation.
ALS affects the autonomic nervous system initially by
invoking degeneration of neurons that lead to sympathetic
predominance and vagal withdrawal. In ALS there* Correspondence: Kamal.Shemisa@uhhospitals.org
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of preganglionic sympathetic ganglia. We therefore
hypothesized that patients with ALS may have a predilec-
tion to the development of cardiac conduction disorders.
We then examined the prevalence of heart block via
a national database and conducted a literature search
to explain the pathogenesis of heart block in a patient
with ALS.
Case presentation
Our patient was a 65-year-old Caucasian man with an
18-month history of ALS, who presents with progressive
dyspnea and palpitations. A previous evaluation of his
dyspnea attributed the cause to neuromuscular weakness
and he underwent a pulmonary evaluation. A chest X-ray
demonstrated clear lung fields. His arterial blood gas
revealed a pH 7.4, carbon dioxide partial pressure 62,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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40% and concomitant blood chemistry demonstrated
elevated serum bicarbonate, both consistent with chronic
carbon dioxide retention. Pulmonary function testing
indicated a forced expiratory volume in 1 second (FEV1)
of 79% and FEV1/forced vital capacity of >80%. These
pulmonary function tests did not represent a significant
decrement from baseline.
An electrocardiogram (ECG) was obtained which
demonstrated hemodynamically stable new third degree
atrioventricular (AV) block with a junctional escape rate
of 50 beats per minute (Figure 1). A previously obtained
ECG indicated normal sinus rhythm. On further review, he
was not prescribed medications with AV nodal blocking
properties while at home or during his hospitalization. On
echocardiogram, a structurally normal heart was observed
with normal left ventricular dimensions and function
without significant valvular disease. He was offered a
permanent dual chamber pacemaker for definitive
treatment, however, he declined.
We believe that his symptoms were probably attributable
to his AV block. The original symptoms of dyspnea with
palpitations were initially attributed to ALS neuromuscular
weakness during periods of exertion. The narrow complex
escape rhythm suggested the block occurred at or above
the level of the AV node, an area innervated by the
autonomic nervous system. The role of ALS as the
etiology for the development of AV block has not
been previously reported. However, given the association of
autonomic dysfunction with ALS, conduction abnormalities
might be expected.
Determining associations of disease can be difficult and
often requires large data sets to generate conclusions. The
Explorys platform is a system that aggregates standardizedFigure 1 On this 12-lead electrocardiogram, the patient has completeand normalized electronic health record data currently
from 13 healthcare systems around the USA and
thousands of providers’ systems representing 15 million
patients. We conducted a query using the Explorys
Explore tool of patients with ALS and any degree of
heart block (1st, 2nd, and 3rd degree) using International
Classification of Diseases, Ninth Revision, diagnosis
codes for both conditions (ALS =335.20, Heart block =426.0,
426.11, 426.12, 426.13). We sought to determine the
difference between the prevalence of heart block in
the general population and in those with ALS.
In Explorys, there was a base of 14,092,470 patients of
which 3470 had ALS. Heart block was present in 73,801
patients without ALS and in 30 patients with ALS. The
prevalence in the diagnosis of heart block in the general
population was 0.52%. In ALS the prevalence of the
diagnosis of heart block was 0.86%. The difference in
prevalence of heart block was therefore estimated to be
25% higher in patients with ALS (P-value 0.01; confidence
interval 0.002 to 0.100).
Discussion
ALS is a neurodegenerative disorder affecting both upper
and lower motor neurons. Patients eventually succumb to
total paralysis and respiratory failure. Research efforts
have focused on the improvement and prevention of
further neuromuscular deterioration and the management
of respiratory failure.
Cardiovascular consequences related to ALS are
relatively underappreciated. In fact, it is believed that
concomitant heart diseases are rare in ALS [1]. Like
Parkinson’s disease and Shy–Drager syndrome, ALS
affects the autonomic nervous system which contributes
to regulation of heart rate, blood pressure and otherheart block with an escape rhythm of 50 beats per minute.
Shemisa et al. Journal of Medical Case Reports 2014, 8:224 Page 3 of 4
http://www.jmedicalcasereports.com/content/8/1/224homeostatic functions. In fact, the course of autonomic
dysfunction begins with vagal withdrawal and sympathetic
predominance followed by sympathetic denervation and
vagal predominance. Therefore, it is not surprising that
patients with ALS may experience palpitations, dizziness,
dyspnea and syncope [2,3]. However, there is little
understanding of the contribution of ALS to cardiac
arrhythmias. Given that patients with ALS frequently
have predominantly respiratory symptoms, diagnosis
and treatment of cardiac arrhythmias can be difficult.
An appreciation that impairments in the autonomic
reflex loop contribute to these cardiac manifestations
and are part of the natural progression of disease is
necessary for detection and diagnosis.
Early autonomic dysfunction
Autonomic dysfunction in ALS is common. Autonomic
aberrations were first reported in small series that
showed reductions in blood pressure during sustained
hand grip [4]. Later observations described a discrepancy
between sympathetic and parasympathetic tone. In fact,
patients with ALS often exhibit bulbar dysfunction
impacting centrally mediated vagal and sympathetic
nerves with resultant greater autonomic dysfunction.
The impact of ALS upon the autonomic nervous system
is sympathetic predominance and vagal withdrawal [5,6].
Cardiovascular autonomic testing which included analysis
of heart rate variability and baroreflex function analysis
were used to study those effects [2,3]. The consequences
of disruptions in the autonomic reflex loop on the
cardiovascular system include chronotropic incompetence
and vasomotor instability. Previous research measuring
muscle sympathetic nerve activity indicates higher levels
of sympathetic activation in ALS [2,7]. Animal studies
using the ALS-mouse model (the superoxide dismutase 1,
SOD1, knockout mouse) have demonstrated persistent
mydriasis with infusion of morphine compared to wild
type. This suggests greater sympathetic nervous activity in
the ALS mouse [8,9].
In addition, in ALS there is a loss of baroreflex response
and perturbations of preganglionic sympathetic ganglia
[10,11]. Studies using baroreflex stimulation indicate
impaired vagal responses with preservation or enhance-
ment of sympathetic activation [5]. For example, elevated
blood pressure in ALS can be described as disproportionate
alpha-sympathetic hyperactivity. Further, patients with ALS
experience loss of heart rate variability and enhanced
vasomotor responses [3,12]. Discordance between blood
pressure and heart rate reflects sympathetic and parasym-
pathetic nervous system imbalance.
Late autonomic dysfunction
Cardiovascular autonomic dysfunction contributes to
the morbidity of the disease. Perhaps the progression ofautonomic dysfunction in ALS is under-reported. As
previously described, sympathetic predominance with vagal
withdrawal tends to occur early on in disease. However, in
advanced ALS, the spinal cord sympathetic ganglia
known as the intermediolateral nucleus also undergoes de-
generation [6,13,14]. In addition to late central sympathetic
failure, there is also degeneration of peripherally mediated
sympathetic nerves. Electrophysiological testing using sym-
pathetic skin response demonstrated that sequential
loss of sympathetic efferents occurs late in disease progres-
sion [15]. Evidence of cardiac sympathetic denervation
using metaiodobenzylguanidine-single-photon emission
computed tomography (SPECT) has also been shown [16].
One marker of cardiac sympathetic denervation is ECG-
associated QT interval prolongation [13]. Heterogeneous
QT prolongation may predispose patients to potentially
life-threatening arrhythmias.
Cardiac arrhythmias
Arrhythmias associated with ALS may occur as a result of
autonomic dysfunction. The most common arrhythmic
manifestations are sinus tachycardia resulting from vagal
withdrawal, interval prolongations of the QT interval,
and bradycardia due to sympathetic denervation [10].
Disruptions in the autonomic reflex loop prevent sympa-
thetic activation of vasomotor alpha-receptors to interrupt
tachycardia via vagal mechanisms.
In drug treatment studies, abnormal augmentation
of sympathetic tone in ALS make directed treatments
for hypertension and tachycardia difficult. In infusion
experiments with low doses of phentolamine, an alpha-
antagonist, abrupt drops in blood pressure occurred and
only modest increases in heart rate were observed. Likewise
beta-antagonism with propranolol leads to considerable
decreases in both blood pressure and heart rate with
prolonged bradycardia [17]. As reported in one study, sym-
pathetic denervation causes delays in cardiac repolarization
leading to QT prolongation [13].
Bradycardia likewise can be explained in ALS by
sympathetic denervation followed by the predominance of
vagal function. Autonomic dysfunction begins with vagal
release with enhanced sympathetic tone causing tachycar-
dia. As patients later progress in ALS, sympathetic denerv-
ation occurs, followed by vagal predominance, leading
to the development of bradycardia [6,13]. In a study
examining the effects of vagal tone on the sinoatrial
node and AV node, in patients with history of syn-
cope, sinus arrest or bradycardia, it was found that
increased vagal tone contributed to prolongation in
the sinus cycle length as well as the AV node. Given
that the prolongation across the AV node is a vagally
mediated process, the conditions for enhanced AV
nodal blockade are likely exaggerated in patients with
advanced ALS [18].
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The cardiovascular manifestations of ALS are often an
understated problem encountered through the course of
the disease. Concomitant autonomic dysfunction in ALS
seems to play a large role in the pathogenesis and
the natural history for both vasomotor instability and
cardiac arrhythmias. While ALS is a progressive illness that
leads to eventual respiratory failure from neuromuscular
weakness, the autonomic dysfunction is similarly pro-
gressive. It begins with vagal disruption, followed by
enhanced sympathetic activity and eventually sympathetic
denervation with vagal predominance.
The degree of autonomic dysfunction may offer insight
into the natural course of the disease. As in the patient
presented, AV nodal block argues that sympathetic
denervation had occurred and suggests advanced ALS.
Cardiac arrhythmias are often untreated and symptoms
are often attributed to a pulmonary or psychiatric cause.
This is the first reported case of complete heart block
occurring in ALS.
While the findings are not well documented in the
literature, the findings are well supported by previous
physiological studies in ALS as well as a survey from
a reputable database. Utilizing the data from the Explorys
platform, there was a higher prevalence of heart block in
patients with ALS. While the small number of affected
individuals confers some statistical uncertainty, it suggests
that a degree of AV block occurs more frequently in
patients with ALS. Autonomic dysfunction occurs in other
neurodegenerative illnesses and may shed light into their
disease progression as well as potential treatment.Consent
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